The Effect of CYP Polymorphism on Resistance against Praziquantel in Clonorchis Sinensis-infected Patients |
Kim, Chung-Hyeon
(Department of Internal Medicine, Healthcare System Gangnam Center, Seoul National University Hospital)
Choi, Min-Ho (Department of Parasitology, Seoul National University, College of Medicine) Chae, Jong-Il (Department of Parasitology, Seoul National University, College of Medicine) Shin, Eun-Hee (Department of Parasitology, Seoul National University, College of Medicine) Hong, Sung-Tae (Department of Parasitology, Seoul National University, College of Medicine) |
1 | Rim, H. J. The current pathobiology and chemotherapy of clonorchiasis. Korean J Parasitol 28(suppl):4-151 (1986) |
2 | Hustert, E. et al. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11:773-779 (2001) DOI |
3 | Silvestri, L. et al. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int J Cancer 104:310-317 (2003) DOI ScienceOn |
4 | Cioli, D. et al. Praziqualtel. Parasitol Res 90:S3-S9(2003) |
5 | Seo, B. S. et al. Praziqualtel () in treatment of Clonorchis sinensis infection. Korean J Parasitol 21:241-245 (1983) DOI ScienceOn |
6 | Saito, S. et al. 906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDLs) in the Japanese population. J Hum Genet 27:419-444 (2002) |
7 | Giorgi. M. et al. Pharmacokinetics and microsomal oxidation of praziquantel and its effects on the P450 system in three-month-old lambs infested by Fasciola hepatica. J Vet Pharmacol Therap 24:251-259 (2001) DOI ScienceOn |
8 | Ingelman-Sundberg, M. et al. Polymorphism of cytochrome P450 and xenobiotic toxicity. Toxicology 181-182:447-452 (2002) DOI ScienceOn |